Addressing policy barriers to scaling up needle and syringe programmes: a global call to action
Year: 2025
Type: article
Language: en
Topic: HIV, Drug Use, Sexual Risk
Authors and affiliations:
raw_author_name: Guillaume Fontaine
raw_affiliation_strings: McGill University, Montréal, QC, Canada; Lady Davis Institute for Medical Research, Montréal, QC, Canada; Ottawa Hospital Research Institute, Ottawa, ON, Canada; Kirby Institute, University of New South Wales, Kensington, NSW, Australia. Electronic address: guil.fontaine@mcgill.ca
raw_author_name: Emma Day
raw_affiliation_strings: International Network on Health and Hepatitis in Substance Users, Barangaroo, NSW, Australia
raw_author_name: Niklas Luhmann
raw_affiliation_strings: WHO, Geneva, Switzerland
raw_author_name: Annie Madden
raw_affiliation_strings: International Network of People Who Use Drugs, Barton, ACT, Australia
raw_author_name: Keith Sabin
raw_affiliation_strings: UNAIDS, Geneva, Switzerland
raw_author_name: Andrew Scheibe
raw_affiliation_strings: TB HIV Care, Cape Town, South Africa; University of Pretoria, Hatfield, South Africa; University of Bristol, Bristol, UK
raw_author_name: Mark Stoove
raw_affiliation_strings: Burnet Institute, Melbourne, VIC, Australia
raw_author_name: Peter Vickerman
raw_affiliation_strings: University of Bristol, Bristol, UK
raw_author_name: Ernst Wisse
raw_affiliation_strings: Médecins du Monde, Paris, France
raw_author_name: Jason Grebely
raw_affiliation_strings: Kirby Institute, University of New South Wales, Kensington, NSW, Australia; International Network on Health and Hepatitis in Substance Users, Barangaroo, NSW, Australia
raw_author_name: Natalie Taylor
raw_affiliation_strings: Implementation to Impact (i2i), School of Population Health, University of New South Wales, Kensington, NSW, Australia
raw_author_name: Philip Bruggmann
raw_author_name: Judy Chang
raw_author_name: Emily Christie
raw_author_name: Monica Ciupagea
raw_author_name: Colleen Daniels
raw_author_name: Emma Day
raw_affiliation_strings: International Network on Health and Hepatitis in Substance Users, Barangaroo, NSW, Australia
raw_author_name: Jason Grebely
raw_affiliation_strings: Kirby Institute, University of New South Wales, Kensington, NSW, Australia; International Network on Health and Hepatitis in Substance Users, Barangaroo, NSW, Australia
raw_author_name: Kim Green
raw_author_name: Kiera Gustafson
raw_author_name: Jennifer Hasselgard Rowe
raw_author_name: Niklas Luhmann
raw_affiliation_strings: WHO, Geneva, Switzerland
raw_author_name: Annie Madden
raw_affiliation_strings: International Network of People Who Use Drugs, Barton, ACT, Australia
raw_author_name: Natasha Martin
raw_author_name: Susie McLean
raw_author_name: Keith Sabin
raw_affiliation_strings: UNAIDS, Geneva, Switzerland
raw_author_name: Andrew Scheibe
raw_affiliation_strings: TB HIV Care, Cape Town, South Africa; University of Pretoria, Hatfield, South Africa; University of Bristol, Bristol, UK
raw_author_name: Heather Marie Schmidt
raw_author_name: Mat Southwell
raw_author_name: Mark Stoove
raw_affiliation_strings: Burnet Institute, Melbourne, VIC, Australia
raw_author_name: Karin Timmermans
raw_author_name: Anna Tomasi
raw_author_name: Beatrix Vas
raw_author_name: Annette Verster
raw_author_name: Peter Vickerman
raw_affiliation_strings: University of Bristol, Bristol, UK
raw_author_name: Ancella Voets
raw_author_name: Ernst Wisse
raw_affiliation_strings: Médecins du Monde, Paris, France